Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMD and/or Bone Substitute for Mandibular Class II Furcation Defects
NCT02474498Phase 4Completed
- Sponsor
- Universidade Estadual de Campinas
- Start
- Mar 2013
- Primary completion
- Dec 2014
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
A Phase 4 trial of enamel matrix derivative in periodontal disease, sponsored by Universidade Estadual de Campinas. Started Mar 2013; status: completed.
02
Drugs
enamel matrix derivative
03
Conditions
periodontal disease
Beyond the preview
Go deeper on NCT02474498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02474498.